A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

A new study has confirmed that weight loss or bariatric surgery is safe and very effective, and, for a large percentage of ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...

Weight loss drugs continue to make headlines.  A new study conducted by researchers from the University of Southern ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Ozempic made headlines after a study came out linking this and similar medications like Wegovy to an eye condition that can cause irreversible damage and permanent vision loss, including total ...

A new study suggests that using weight loss drugs such as Ozempic and Wegovy can lead to less alcohol consumption. The study, ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.